The Study of GR1802 in Patients with Chronic Rhinosinusitis with Nasal Polyps

NCT05873803 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Rhinosinusitis with Nasal Polyps

Interventions

BIOLOGICAL: GR1802 injection
BIOLOGICAL: placebo

Sponsor

Genrix (Shanghai) Biopharmaceutical Co., Ltd.